Project Details
Description
A Phase 2, Multicenter, Open-Label, Single Arm, Two-Stage Study to Evaluate the Efficacy and Safety of CC-4047 (Pomalidomide)in Patients with Advanced Soft
| Status | Finished |
|---|---|
| Effective start/end date | 2/9/08 → 12/31/13 |
Funding
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.